These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9777699)

  • 1. Prevention of hyperacute rejection by phosphatidylinositol-anchored mini-complement receptor type 1.
    Mikata S; Miyagawa S; Yoshitatsu M; Ikawa M; Okabe M; Matsuda H; Shirakura R
    Transpl Immunol; 1998 Jun; 6(2):107-10. PubMed ID: 9777699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein.
    Mikata S; Miyagawa S; Iwata K; Nagasawa S; Hatanaka M; Matsumoto M; Kamiike W; Matsuda H; Shirakura R; Seya T
    Transplantation; 1998 Feb; 65(3):363-8. PubMed ID: 9484752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hyperacute rejection by phosphatidylinositol-anchored factor I.
    Yoshitatsu M; Miyagawa S; Murase A; Matsunami K; Yamada M; Sawa Y; Ohtake S; Matsuda H; Shirakura R
    Transplant Proc; 2000 Aug; 32(5):905-6. PubMed ID: 10936267
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
    Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T
    Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A surface-bound form of human C1 esterase inhibitor improves xenograft rejection.
    Matsunami K; Miyagawa S; Yamada M; Yoshitatsu M; Shirakura R
    Transplantation; 2000 Mar; 69(5):749-55. PubMed ID: 10755521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Kitamura H; Seya T
    Scand J Immunol; 1993 Jul; 38(1):37-44. PubMed ID: 7687071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells.
    Leslie RG
    Immunology; 1999 Jul; 97(3):371-3. PubMed ID: 10447756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human soluble complement receptor 1 by a pig endothelial cell line inhibits lysis by human serum.
    Manzi L; Montaño R; Abad MJ; Arsenak M; Romano E; Taylor P
    Xenotransplantation; 2006 Jan; 13(1):75-9. PubMed ID: 16497215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
    Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
    Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
    White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
    Transpl Int; 1992; 5 Suppl 1():S648-50. PubMed ID: 14621899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.
    Miyagawa S; Shirakura R; Iwata K; Nakata S; Matsumiya G; Izutani H; Matsuda H; Terado A; Matsumoto M; Nagasawa S
    Transplantation; 1994 Oct; 58(7):834-40. PubMed ID: 7524206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.
    Charreau B; Ménoret S; Tesson L; Azimzadeh A; Audet M; Wolf P; Marquet R; Verbakel C; Ijzermans J; Cowan P; Pearse M; d'Apice A; Soulillou JP; Anegon I
    Mol Med; 1999 Sep; 5(9):617-30. PubMed ID: 10551903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
    Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
    Heckl-Ostreicher B; Binder R; Kirschfink M
    Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of human factor H and I on xenosurface.
    Yoshitatsu M; Miyagawa S; Mikata S; Matsunami K; Yamada M; Murase A; Sawa Y; Ohtake S; Matsuda H; Shirakura R
    Biochem Biophys Res Commun; 1999 Nov; 265(2):556-62. PubMed ID: 10558908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
    van Beek J; van Meurs M; 't Hart BA; Brok HP; Neal JW; Chatagner A; Harris CL; Omidvar N; Morgan BP; Laman JD; Gasque P
    J Immunol; 2005 Feb; 174(4):2353-65. PubMed ID: 15699172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
    Guc D; Canpinar H; Kucukaksu C; Kansu E
    Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.